Literature DB >> 1318260

Predicting cocaine use among methadone patients: analysis of findings from a national study.

G H Dunteman1, W S Condelli, J A Fairbank.   

Abstract

Findings from a large-scale national study of clients admitted to publicly funded drug treatment programs between 1979 and 1981 were used to determine whether cocaine use by current and former methadone patients could be predicted. The sample for this analysis comprised 526 daily or weekly heroin users admitted to 17 methadone maintenance programs. The study found that cocaine use by both current and former methadone patients showed an overall decline during the follow-up year; that patients who stopped using heroin after entering treatment were much more likely to quit using cocaine than were their heroin-using counterparts; and that the odds of initiating cocaine use after admission to a methadone program were much higher among patients who continued using heroin. These findings suggest that methadone programs may be able to reduce cocaine use among some patients by improving their effectiveness in reducing heroin use.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318260     DOI: 10.1176/ps.43.6.608

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  10 in total

1.  [Maintenance treatment in opioid-dependent patients with migration background].

Authors:  L K Bald; M Schouler-Ocak; S Penka; N Schoofs; T Häbel; F Bermpohl; S Gutwinski
Journal:  Nervenarzt       Date:  2016-05       Impact factor: 1.214

2.  Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression.

Authors:  Francesco Leri; Yan Zhou; Brendan Carmichael; Erin Cummins; Mary Jeanne Kreek
Journal:  Eur Neuropsychopharmacol       Date:  2011-07-13       Impact factor: 4.600

3.  Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen?

Authors:  Jeremiah Weinstock; Carla J Rash; Nancy M Petry
Journal:  Psychol Addict Behav       Date:  2010-06

4.  Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.

Authors:  Francesco Leri; Yan Zhou; Benjamin Goddard; AnneMarie Levy; Derek Jacklin; Mary Jeanne Kreek
Journal:  Eur Neuropsychopharmacol       Date:  2008-11-06       Impact factor: 4.600

5.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382

6.  Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.

Authors:  D M Hartel; E E Schoenbaum; P A Selwyn; J Kline; K Davenny; R S Klein; G H Friedland
Journal:  Am J Public Health       Date:  1995-01       Impact factor: 9.308

7.  Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.

Authors:  Sandra D Comer; Maria A Sullivan; Elmer Yu; Jami L Rothenberg; Herbert D Kleber; Kyle Kampman; Charles Dackis; Charles P O'Brien
Journal:  Arch Gen Psychiatry       Date:  2006-02

8.  ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.

Authors:  Catherine J Spellicy; Thomas R Kosten; Sara C Hamon; Mark J Harding; David A Nielsen
Journal:  Pharmacogenet Genomics       Date:  2013-07       Impact factor: 2.089

9.  Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.

Authors:  Huiru Dong; Kanna Hayashi; M-J Milloy; Kora DeBeck; Joel Singer; Hubert Wong; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2020-04-25       Impact factor: 4.492

10.  Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study.

Authors:  Marcus Baumeister; Marc Vogel; Kenneth M Dürsteler-MacFarland; Urs Gerhard; Johannes Strasser; Marc Walter; Gerhard A Wiesbeck; Sylvie A Petitjean
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.